AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 20200268
Drug: Sergliflozin etabonate
RxNorm normalized name: Loteprednol Etabonate
DrugBank: Loteprednol etabonate (DB14596)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sergliflozin etabonate 1000 mg
Trial: 20200268
Drug: Sergliflozin etabonate
RxNorm normalized name: Loteprednol Etabonate
DrugBank: Loteprednol etabonate (DB14596)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sergliflozin etabonate 500 or 1000 mg
Trial: 15657326
Drug: Estrogen plus
RxNorm normalized name: estrogens
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Estrogen plus progestin (E + P), given as CEE plus 2.5 mg/d of medroxyprogesterone acetate
Trial: 10492316
Drug: Subcutaneous calcium-heparin
RxNorm normalized name: HEPARIN CALCIUM
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subcutaneous calcium-heparin (12,500 IU/day)
Trial: 8758169
Drug: Epidural infusion
RxNorm normalized name: epidural administration set EPIDURAL INFUSION SETS-PARAPHERNALIA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epidural infusion of 0.06% bupivacaine with fentanyl 4 micrograms.ml‐1 (group F)
Trial: 8758169
Drug: Epidural infusion
RxNorm normalized name: epidural administration set EPIDURAL INFUSION SETS-PARAPHERNALIA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epidural infusion of 0.06% bupivacaine with pethidine 1.5 mg.ml‐1 (group P)
Trial: 8758169
Drug: Epidural infusion
RxNorm normalized name: epidural administration set EPIDURAL INFUSION SETS-PARAPHERNALIA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epidural infusion rates in both groups
Trial: 25175921
Drug: Prehospital ticagrelor
RxNorm normalized name: Ticagrelor
DrugBank: Ticagrelor (DB08816)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Prehospital ticagrelor administration
Trial: 25175921
Drug: In-hospital ticagrelor
RxNorm normalized name: Ticagrelor
DrugBank: Ticagrelor (DB08816)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: In-hospital ticagrelor administration
Trial: 19800815
Drug: Amiodarone (150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amiodarone (150 mg in 10 mL of normal saline)
Trial: 19809326
Drug: Amiodarone (150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amiodarone (150 mg)
Trial: 17922444
Drug: Erythropoiesis-stimulating agents
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Erythropoiesis-stimulating agents for hemoglobin normalization
Trial: 17922444
Drug: New agents
FDA approved: no
EMA approved: no
PMDA approved: no
Description: New agents for calcium-phosphate metabolism (phosphate binders not containing calcium and aluminum, vitamin D analogs with lower calcemic activity, calcimimetics)
Trial: 16392704
Drug: Green tea
RxNorm normalized name: Green Tea
DrugBank: Green tea leaf (DB14307)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Green tea extracts/powder containing 544 mg polyphenols (456 mg catechins) daily for 2 months
Trial: 12480476
Drug: Visual context
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Visual context supporting the preferred interpretation of the ambiguous phrase (e.g., 'Put the apple on the towel in the box')
Trial: 2523647
Drug: Captopril plus
RxNorm normalized name: Captopril
DrugBank: Captopril (DB01197)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Captopril plus Isradipine (1.25 mg twice daily)
Trial: 2523647
Drug: Captopril plus
RxNorm normalized name: Captopril
DrugBank: Captopril (DB01197)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Captopril plus Hydrochlorothiazide (12.5 mg per day)
Trial: 326384
Drug: CMF chemotherapy
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CMF chemotherapy for 12 monthly cycles
Trial: 23197840
Drug: Concurrent somatic
RxNorm normalized name: Bos taurus somatic nerve preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Concurrent somatic depressive symptoms
Trial: 23197840
Drug: Concurrent affective
RxNorm normalized name: Solutions affecting the electrolyte balance
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Concurrent affective depressive symptoms
Trial: 23197840
Drug: Concurrent anxiety
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Concurrent anxiety symptoms
Trial: 14505443
Drug: Routine hospice
RxNorm normalized name: chlorhexidine
DrugBank: Chlorhexidine (DB00878)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Routine hospice services and clinical music therapy
Trial: 10866713
Drug: Ephedrine (0.08
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ephedrine (0.08 mg x kg‐1 intravenously)
Trial: 10866713
Drug: Etilefrine (0.02
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Etilefrine (0.02 mg x kg‐1 intravenously)
Trial: 9109708
Drug: Narrow-band red
RxNorm normalized name: Band-Aid Hurt-Free
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Narrow-band red light phototherapy at 660 nm for 4.4 minutes three times a day for 14 days (total dose 6 joules per day)
Trial: 1470889
Drug: Taurolin (topical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Taurolin (topical application)
Trial: 1470889
Drug: Chlortetracycline (Aureomycin,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chlortetracycline (Aureomycin, topical application)
Trial: 2863090
Drug: Beclomethasone dipropionate
RxNorm normalized name: Beclomethasone Dipropionate
DrugBank: Beclomethasone dipropionate (DB00394)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Beclomethasone dipropionate aqueous nasal spray
Trial: 22606044
Drug: Donepezil plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Donepezil plus natural hirudin (3 g/day)
Trial: 22606044
Drug: Donepezil (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Donepezil (5 mg/day for the first 4 weeks and 10 mg/day thereafter)
Trial: 20537124
Drug: Internet group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Internet group (n = 101) that monitored asthma control weekly with the ACQ on the Internet and adjusted treatment using a self‐management algorithm supervised by an asthma nurse specialist
Trial: 12136399
Drug: 5-methyltetrahydrofolate (5-MTHF,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5-methyltetrahydrofolate (5-MTHF, 1 microg/100 ml FAV/min)
Trial: 10654798
Drug: 111In‐labelled resin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 111In‐labelled resin (150‐300 microm) administered in the morning (0800h)
Trial: 10654798
Drug: 99mTc‐labelled non‐disintegrating
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 99mTc‐labelled non‐disintegrating capsule (22 x 8 mm) administered in the morning (0800h)
Trial: 10654798
Drug: 111In‐labelled resin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 111In‐labelled resin (150‐300 microm) administered in the evening (1700h)
Trial: 10654798
Drug: 99mTc‐labelled non‐disintegrating
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 99mTc‐labelled non‐disintegrating capsule (22 x 8 mm) administered in the evening (1700h)
Trial: 2194270
Drug: IVIG (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IVIG (1 g/d)
Trial: 7008062
Drug: Prostacyclin infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prostacyclin infusion at a dosage of 8 ng/kg/min
Trial: 30601837
Drug: Reappraisal (twice)
RxNorm normalized name: Tice BCG
DrugBank: Bacillus calmette-guerin substrain tice live antigen (DB10343)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Reappraisal (twice)
Trial: 30601837
Drug: Rumination (twice)
RxNorm normalized name: Tice BCG
DrugBank: Bacillus calmette-guerin substrain tice live antigen (DB10343)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rumination (twice)
Trial: 29602751
Drug: Ivermectin 600
RxNorm normalized name: Ivermectin
DrugBank: Ivermectin (DB00602)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ivermectin 600 μg/kg per day for 3 days
Trial: 29602751
Drug: Ivermectin 300
RxNorm normalized name: Ivermectin
DrugBank: Ivermectin (DB00602)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ivermectin 300 μg/kg per day for 3 days
Trial: 26294205
Drug: Pelvic floor
RxNorm normalized name: Tenscare Kegel Toner Pelvic Floor Trainer
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pelvic floor muscle training (PFMT) daily program from 20 to 36 weeks' gestation
Trial: 16841630
Drug: Olanzapine-fluoxetine combination
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Olanzapine-fluoxetine combination
Trial: 10688033
Drug: Human chorionic
RxNorm normalized name: human chorionic gonadotropin
DrugBank: Chorionic Gonadotropin (Human) (DB09126)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Human chorionic gonadotropin (HCG) treatment
Trial: 9095326
Drug: Combination regimen
RxNorm normalized name: Anacin Aspirin Regimen Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination regimen (metoclopramide, dexamethasone, lorazepam, orphenadrine)
Trial: 8459263
Drug: Chemoprophylaxis and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemoprophylaxis and immunoprophylaxis (thymostimulin 70 mg i.m. per day for 7 days + 2 g cefotetan at induction)
Trial: 8459263
Drug: Chemoprophylaxis only
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemoprophylaxis only (2 g cefotetan at induction)
Trial: 3516016
Drug: Intravenous lidocaine,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous lidocaine, 3 mg/kg, followed by an infusion of 0.05 mg X kg‐1 X min‐1
Trial: 3516016
Drug: Intravenous lidocaine,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous lidocaine, 3 mg/kg
Trial: 28899879
Drug: Higher protein
RxNorm normalized name: protein C
DrugBank: Protein C (DB11312)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Higher protein intake (2.4 g/kg/d)
Trial: 28899879
Drug: Lower protein
RxNorm normalized name: protein C
DrugBank: Protein C (DB11312)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lower protein intake (1.2 g/kg/d)
Trial: 27378474
Drug: Losartan 100
RxNorm normalized name: LOSARTAN 100MG TAB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Losartan 100 mg/day
Trial: 12766602
Drug: 1 day
RxNorm normalized name: ZonaCort 11 Day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 day protocol (morning injection and afternoon surgery)
Trial: 12766602
Drug: 2 day
RxNorm normalized name: Sterapred 12 DAY
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 day protocol (day before afternoon injection and morning surgery)
Trial: 12766602
Drug: Lower doses
RxNorm normalized name: flowers
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lower doses of 99mTc‐rhenium sulphide colloid
Trial: 10487404
Drug: Anethole trithione
RxNorm normalized name: anethole trithione
DrugBank: Anethole trithione (DB13853)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anethole trithione (AT) - 6 tablets per day
Trial: 7588175
Drug: Intravenous administration
RxNorm normalized name: intravenous administration set
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous administration of antidepressants
Trial: 3407609
Drug: 45 mg
RxNorm normalized name: lutein 45 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 45 mg beta-carotene
Trial: 3407609
Drug: 45 mg
RxNorm normalized name: lutein 45 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 45 mg beta-carotene (daily dosing)
Trial: 3407609
Drug: Pharmacological doses
RxNorm normalized name: COPD pharmacologic substance
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pharmacological doses of beta-carotene (45 and 90 mg)
Trial: 764997
Drug: Trivalent vaccine
RxNorm normalized name: Fluzone 2024-2025 trivalent vaccine Injectable Suspension
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trivalent vaccine (measles, mumps, rubella)
Trial: 28289865
Drug: Pimasertib tablet
RxNorm normalized name: Capivasertib
DrugBank: Pimasertib (DB14904)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pimasertib tablet (3 × 20 mg, PO QD)
Trial: 28289865
Drug: Pimasertib capsule
RxNorm normalized name: Capivasertib
DrugBank: Pimasertib (DB14904)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pimasertib capsule (2 × 30 mg, PO QD)
Trial: 23478893
Drug: Full-dose protocol
RxNorm normalized name: Rho(D) immune globulin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Full-dose protocol (group A)
Trial: 23478893
Drug: Half-dose protocol
RxNorm normalized name: propranolol hydrochloride Extended Release Oral Capsule [Half-Betadur CR]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Half-dose protocol (group B)
Trial: 21320171
Drug: Platform switching
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Platform switching with a 3.3 mm diameter abutment on test implants
Trial: 21320171
Drug: Control implant
RxNorm normalized name: Drug Implant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control implant with a straight 4 mm diameter abutment
Trial: 21320171
Drug: Comparison of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Comparison of test and control implants
Trial: 21320171
Drug: Bacterial contamination
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bacterial contamination in implants
Trial: 8041168
Drug: Surgical intervention
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Surgical intervention and antibiotics
Trial: 162669
Drug: Diclofenac sodium
RxNorm normalized name: Diclofenac Sodium
DrugBank: Diclofenac (DB00586)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Diclofenac sodium (Voltaren) 25 mg t.i.d.
Trial: 30889044
Drug: Intra-Aortic Balloon
RxNorm normalized name: somatropin
DrugBank: Somatotropin (DB00052)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intra-Aortic Balloon Pump (IABP) therapy
Trial: 27502326
Drug: Fimasartan/Amlodipine 60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fimasartan/Amlodipine 60 mg/10 mg
Trial: 15634953
Drug: 7-valent pneumococcal
RxNorm normalized name: Streptococcus pneumoniae serotype 10A capsular antigen diphtheria CRM197 protein conjugate vaccine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 7-valent pneumococcal conjugate vaccine (PV)
Trial: 463800
Drug: Concurrent energy
RxNorm normalized name: Senergy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Concurrent energy provision
Trial: 31813633
Drug: Obeticholic acid
RxNorm normalized name: Obeticholic acid
DrugBank: Obeticholic acid (DB05990)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Obeticholic acid 25 mg
Trial: 26357703
Drug: Enamel matrix
RxNorm normalized name: Matrix
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enamel matrix derivative (EMD) 0.1 mL topically applied to soft tissues surrounding implants
Trial: 26357703
Drug: Control (no
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (no treatment applied)
Trial: 23351812
Drug: Oral prednisolone
RxNorm normalized name: prednisolone Oral Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral prednisolone for 6 weeks
Trial: 23351812
Drug: Mycobacterium w
RxNorm normalized name: Mycobacterium W Vaccine
DrugBank: Mycobacterium w. Vaccine (DB15798)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mycobacterium w injection for 3 months
Trial: 23351812
Drug: Safety of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Safety of immunomodulatory treatment
Trial: 23351812
Drug: Placebo for
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo for oral prednisolone
Trial: 23351812
Drug: Placebo for
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo for Mycobacterium w injection
Trial: 19247497
Drug: Intravenous opioid
RxNorm normalized name: OPIOIDS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous opioid analgesia and general anesthesia (IV group)
Trial: 17298428
Drug: Methylprednisolone aceponate
RxNorm normalized name: Methylprednisolone aceponate
DrugBank: Methylprednisolone aceponate (DB14643)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methylprednisolone aceponate 0.1% ointment once daily
Trial: 17298428
Drug: Tacrolimus 0.03%
RxNorm normalized name: TACROLIMUS 0.03% OINT,TOP
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tacrolimus 0.03% ointment twice daily
Trial: 17298428
Drug: Methylprednisolone aceponate
RxNorm normalized name: Methylprednisolone aceponate
DrugBank: Methylprednisolone aceponate (DB14643)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methylprednisolone aceponate 0.1% ointment
Trial: 2996332
Drug: Enalapril (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enalapril (10 to 20 mg bid)
Trial: 2996332
Drug: Hydrochlorothiazide (25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hydrochlorothiazide (25 to 50 mg bid)
Trial: 2996332
Drug: Combination therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination therapy (Enalapril + Hydrochlorothiazide)
Trial: 24176534
Drug: Antidepressant medication
RxNorm normalized name: ANTIDEPRESSANTS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antidepressant medication (MED)
Trial: 19835829
Drug: All doses
RxNorm normalized name: All Clear
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: All doses of MF59 with various antigen levels
Trial: 19835829
Drug: Second dose
RxNorm normalized name: sodium fluoride
DrugBank: Sodium fluoride (DB09325)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Second dose of vaccine
Trial: 9821828
Drug: Echinacea treatments
RxNorm normalized name: Echinacea
DrugBank: Echinacea (DB14240)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Echinacea treatments
Trial: 17642235
Drug: Tocilizumab (humanized
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tocilizumab (humanized anti-human IL-6 receptor antibody)
Trial: 15080023
Drug: Barnidipine hydrochloride
RxNorm normalized name: barnidipine hydrochloride
DrugBank: Barnidipine (DB09227)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Barnidipine hydrochloride at a titrated dose of 10-15 mg once daily for 8 weeks
Trial: 11262334
Drug: Dietetic therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dietetic therapy
Trial: 11262334
Drug: HMG-CoA-reductase inhibitors
RxNorm normalized name: HMG CoA reductase inhibitors
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HMG-CoA-reductase inhibitors management
Trial: 8042733
Drug: Intra-articular morphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intra-articular morphine 2 mg in 40 ml of normal saline
Trial: 8042733
Drug: Intramuscular morphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular morphine 2 mg in 1 ml of normal saline
Trial: 1429339
Drug: Selective decontamination
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Selective decontamination of the digestive tract (SDD) consisting of topical polymyxin E, tobramycin, and amphotericin B administered throughout the unit stay together with parenteral ceftazidime for the first three days.
Trial: 31552815
Drug: H. pylori
RxNorm normalized name: H. PYLORI AGENTS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: H. pylori IgG antibody sero-prevalence among Arabs
Trial: 31552815
Drug: H. pylori
RxNorm normalized name: H. PYLORI AGENTS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: H. pylori IgG antibody sero-prevalence among Jews
Trial: 31552815
Drug: CagA IgG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CagA IgG antibody sero-positivity among H. pylori positives in Arabs
Trial: 31552815
Drug: CagA IgG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CagA IgG antibody sero-positivity among H. pylori positives in Jews
Trial: 24943857
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg (2 mL) dexketoprofen
Trial: 24943857
Drug: 2 mL
RxNorm normalized name: ethanol 2 ML/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 mL normal saline (control)
Trial: 11391126
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg entacapone
Trial: 11391126
Drug: 400 mg
RxNorm normalized name: mesna 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 400 mg entacapone
Trial: 9679843
Drug: Fluticasone propionate
RxNorm normalized name: Fluticasone Propionate
DrugBank: Fluticasone propionate (DB00588)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Fluticasone propionate (50 or 100 microg twice daily)
Trial: 2512765
Drug: Misoprostol 800
RxNorm normalized name: Misoprostol
DrugBank: Misoprostol (DB00929)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Misoprostol 800 mcg
Trial: 24809448
Drug: Levodopa/Carbidopa treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Levodopa/Carbidopa treatment for patients with low DβH activity genotypes (CT/TT)
Trial: 24809448
Drug: Placebo treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo treatment for patients with low DβH activity genotypes (CT/TT)
Trial: 24809448
Drug: Levodopa/Carbidopa treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Levodopa/Carbidopa treatment for patients with normal DβH activity genotype (CC)
Trial: 19020325
Drug: Early antiretroviral
RxNorm normalized name: benzyl alcohol
DrugBank: Benzyl alcohol (DB06770)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Early antiretroviral therapy
Trial: 15821274
Drug: Pramlintide mixed
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pramlintide mixed with short-acting insulin
Trial: 15821274
Drug: Pramlintide mixed
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pramlintide mixed with long-acting insulin
Trial: 15821274
Drug: Separate injections
RxNorm normalized name: Atractylis separate root
DrugBank: Atractylodes lancea root (DB14693)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Separate injections of pramlintide and insulin
Trial: 15821274
Drug: Pramlintide and
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pramlintide and insulin mixtures
Trial: 10391163
Drug: 0.5% bupivacaine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5% bupivacaine 10 ml through a subcutaneous catheter
Trial: 10391163
Drug: Dipyrone 500
RxNorm normalized name: dipyrone 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dipyrone 500 mg orally
Trial: 8871418
Drug: Cognitive-behavioral therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive-behavioral therapy plus family management (CBT + FAM)